Dr. Seth M. Miller, MD

Dr. Miller practices at CarolinaEast Medical Center in New Bern, North Carolina, part of Craven County Government.

Dr. Miller's NPI, 1417276668, was assigned on May 27, 2010. Dr. Miller graduated from University of Miami, Miller School of Medicine in 2010. Dr. Miller holds North Carolina license 2015-00790.

Dr. Miller's primary practice is CarolinaEast Medical Center, at 2000 Neuse Blvd, New Bern, NC 28560 in Craven County. The practice phone is (252) 633-8640.

Dr. Miller's primary practice is CarolinaEast Medical Center in New Bern, North Carolina, part of Craven County Government. The medical group on file is CarolinaEast Heart Center, New Bern.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Miller's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Miller is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Miller's licenses on file in 2 states: North Carolina and Pennsylvania.

Dmand AI lists anal cancer radiation, bladder cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Miller treats.

CMS data shows 3,313 Medicare services from Dr. Miller across 23 procedure codes in 2024, for 390 Medicare patients. Medicare paid $227,708 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 390 Medicare patients who saw Dr. Miller in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miller's median patient age at 74, with 34% women.

In 2024, Dr. Miller wrote 217 Medicare Part D claims for 89 patients. 92% of them were for generic drugs. CMS names the drug for 128 of them, across 7 drugs with 11 or more claims each, at $2,000 in total drug cost. In 2023, CMS named 80 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Miller for performance year 2024, reported individually. Dr. Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Miller, published from 2013 to 2018. 2013 was the busiest year, with 3. The most frequent topics are Radiation Oncology, Internship and Residency and Prostatic Neoplasms. Dr. Miller has published most often in Int J Radiat Oncol Biol Phys. Dr. Miller's most frequent co-authors are Ronald C. Chen, MD, Andrew Zhuang Wang, MD and Michael Joseph Eblan, MD.

Dmand AI links Dr. Miller to 1 clinical trial. Conditions studied include Rectal Neoplasms and Rectal Diseases.

CMS Open Payments shows 22 general payments to Dr. Miller from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Augmenix, Inc. paid the most, $98.

Dr. Miller graduated from University of Miami, Miller School of Medicine in 2010.

Dr. Miller is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.